Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published Announced on 29 October 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Net sales are expected to decline by ¥1.0 billion, mainly due to lower sales of organometallic catalysts. As catalyst demand has declined amid oversupply of petrochemical products following expanded production capacity in China, and uncertainty regarding demand for optical materials and other products has also increased, the Company has made a conservative assessment of future plans and expects to recognize a ¥6.5 billion impairment loss on fixed assets related to multi-plant operations as an extraordinary loss. Net income after the application of tax-effect accounting will be revised accordingly.
¥6.5 billion impairment loss on fixed assets related to 4 multi-plant lines and other assets
| Item | Details |
|---|---|
| Net Sales | 18,000 JPY million → 17,000 JPY million（-5.6%） |
| Operating profit | 200 JPY million → 200 JPY million |
| Ordinary income | 100 JPY million → 100 JPY million |
| Profit attributable to owners of the parent | 30 JPY million → -5,400 JPY million |
| Net income per share | 6.13 yen → -1,104.06 yen |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | Announced on 29 October 2025 |
| Previous-period results | Fiscal year ended March 2025: net sales of ¥20,018 million, operating income of ¥566 million, ordinary income of ¥356 million, net income of ¥288 million, and basic earnings per share of ¥58.96 |
| Reason for the revision | Net sales are expected to decline by ¥1.0 billion, mainly due to lower sales of organometallic catalysts. As catalyst demand has declined amid oversupply of petrochemical products following expanded production capacity in China, and uncertainty regarding demand for optical materials and other products has also increased, the Company has made a conservative assessment of future plans and expects to recognize a ¥6.5 billion impairment loss on fixed assets related to multi-plant operations as an extraordinary loss. Net income after the application of tax-effect accounting will be revised accordingly. |
| Details and amount of extraordinary loss | ¥6.5 billion impairment loss on fixed assets related to 4 multi-plant lines and other assets |
| Dividend forecast revision | No change (year-end dividend: ¥50 per share) |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales are expected to decline by ¥1.0 billion, mainly due to lower sales of organometallic catalysts. In addition, catalyst demand has declined amid oversupply of petrochemical products following expanded production capacity in China, while uncertainty regarding future demand for contract-manufactured products such as optical materials has also increased. Following a conservative assessment of future plans, the Company expects to recognize a ¥6.5 billion impairment loss on fixed assets related to multi-plant operations as an extraordinary loss, and has revised net income after the application of tax-effect accounting.